Aerosol Drug Formulation
ARE Labs can help you with the processing of your drug formulation and optimization for therapeutic inhalation delivery. We specialize in respiratory formulation development and processing of drug formulations for aerosol inhalation delivery in dry powder, aqueous suspensions and solution forms. We have experience in processing dry powder drug formulations using planetary ball milling, jet milling, spray drying, encapsulation with cyclone separation techniques for optimizing the drugs particle size and respirable mass for targeting specific nasal mucosal/intra-nasal, upper, lower, and/or deep lung deposition sites.
We also utilize charge masking techniques, controlled particle porosity and use FDA approved lung excipients for drug encapsulation. We screen the API formulations drug using real-time laser diffraction particle sizers and cascade impactors for verification of drug particle size distribution. ARE Labs can also assist you in aerosol delivery device selection and packaging options for your drug formulation and can conduct characterization testing for optimization for targeting the desired drug respired dose concentration.